Literature DB >> 30763464

Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients.

Nadia Soudani1,2,3, Miguela A Caniza4,5, Aia Assaf-Casals2,6, Rouba Shaker2,6, Mireille Lteif2,6, Yin Su7, Li Tang7, Imad Akel2,6, Samar Muwakkit6,8, Ahmad Chmaisse1,2, Maysam Homsi5, Ghassan Dbaibo2,6, Hassan Zaraket1,2.   

Abstract

BACKGROUND: Patients with pediatric cancer have a higher risk of morbidity and mortality because of respiratory viral infections than other patient populations.
OBJECTIVES: To investigate the causative viruses of respiratory infections and their burden among patients with pediatric cancer in Lebanon. STUDY
DESIGN: Nasopharyngeal swabs along with clinical and demographic data were collected from patients with pediatric cancer presenting febrile episodes with upper respiratory tract symptoms. Total nucleic acid was extracted from specimens followed by the real-time PCR analysis targeting 14 respiratory viruses to estimate the frequency of infections.
RESULTS: We obtained 89 nasopharyngeal swabs from patients with pediatric cancer (mean age, 5.8 ± 4.2 years). Real-time PCR confirmed viral infection in 77 swabs (86.5%). Among these, 151 respiratory viruses were detected. Several viruses cocirculated within the same period; respiratory syncytial virus (RSV) being the most common (45.45%), followed by parainfluenza virus (PIV; 26%), influenza type B (26%), human metapneumovirus (24.6%), and human coronavirus (HCoV; 24.6%). Coinfections were detected in 55% of the subjects, and most of them involved RSV with one or more other viruses. A strong correlation was found between PIV, Flu (influenza of any type), RSV, and HCoV with the incidence of coinfections. RSV was associated with lower respiratory tract infections, nasal congestion, bronchitis, and bacteremia. HCoV was associated with bronchiolitis; rhinovirus was associated with hospital admission.
CONCLUSION: Patients with pediatric cancer have a high burden of respiratory viral infections and a high incidence of coinfections. Molecular diagnostics can improve management of febrile episodes and reduce antibiotic use.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  coinfection; patients with pediatric cancer; prevalence; real-time PCR; respiratory tract infections; virus infections

Mesh:

Year:  2019        PMID: 30763464     DOI: 10.1002/jmv.25432

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Epidemiological characteristics and phylogenic analysis of human respiratory syncytial virus in patients with respiratory infections during 2011-2016 in southern China.

Authors:  Hong-Jiao Luo; Xu-Bin Huang; Hui-Ling Zhong; Cong-Xiu Ye; Xin Tan; Kai Zhou; Lei Yuan; Su-Fen Zhang; Xun Zhu; Cui-Ji Lin; Wen-Jun Wang; Lin Xu; Kai-Yuan Cao
Journal:  Int J Infect Dis       Date:  2019-10-18       Impact factor: 3.623

2.  Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children.

Authors:  Yang Li; Lanfang Min; Xin Zhang
Journal:  BMC Pulm Med       Date:  2021-11-26       Impact factor: 3.317

3.  Occurrence of influenza and bacterial infections in cancer patients receiving radiotherapy in Ghana.

Authors:  Augustina K Arjarquah; Evangeline Obodai; Hannah Ayettey Anie; Michael Aning Osei; John Kofi Odoom; Joseph H K Bonney; Eric Behene; Erasmus N Kotey; James Aboagye; Stephen O Nyarko; Jeannette Bentum; Clara Yeboah; Selassie Kumordjie; Bright Agbodzi; Keren Attiku; Gifty Mawuli; Andrew Letizia; William K Ampofo; Osbourne Quaye
Journal:  PLoS One       Date:  2022-07-26       Impact factor: 3.752

Review 4.  Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus.

Authors:  Gaspar A Pacheco; Nicolás M S Gálvez; Jorge A Soto; Catalina A Andrade; Alexis M Kalergis
Journal:  Microorganisms       Date:  2021-06-13

5.  Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy.

Authors:  Andrea Ferrari; Marco Zecca; Carmelo Rizzari; Fulvio Porta; Massimo Provenzi; Maddalena Marinoni; Richard Fabian Schumacher; Roberto Luksch; Monica Terenziani; Michela Casanova; Filippo Spreafico; Stefano Chiaravalli; Francesca Compagno; Federica Bruni; Chiara Piccolo; Laura Bettini; Mariella D'Angiò; Giulia Maria Ferrari; Andrea Biondi; Maura Massimino; Adriana Balduzzi
Journal:  Pediatr Blood Cancer       Date:  2020-05-26       Impact factor: 3.838

6.  The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience.

Authors:  Aia Assaf-Casals; Zeina Saleh; Sarah Khafaja; Danielle Fayad; Hady Ezzeddine; Mohammad Saleh; Sarah Chamseddine; Rouba Sayegh; Sima L Sharara; Ahmad Chmaisse; Souha S Kanj; Zeina Kanafani; Rima Hanna-Wakim; George F Araj; Rami Mahfouz; Reiko Saito; Hiroshi Suzuki; Hassan Zaraket; Ghassan S Dbaibo
Journal:  BMC Infect Dis       Date:  2020-05-12       Impact factor: 3.090

Review 7.  Hematological manifestations of SARS-CoV-2 in children.

Authors:  Chrysoula Kosmeri; Epameinondas Koumpis; Sophia Tsabouri; Ekaterini Siomou; Alexandros Makis
Journal:  Pediatr Blood Cancer       Date:  2020-10-03       Impact factor: 3.167

8.  SARS-CoV-2 disease and children under treatment for cancer.

Authors:  Monica Terenziani; Maura Massimino; Veronica Biassoni; Michela Casanova; Stefano Chiaravalli; Andrea Ferrari; Roberto Luksch; Cristina Meazza; Marta Podda; Elisabetta Schiavello; Filippo Spreafico
Journal:  Pediatr Blood Cancer       Date:  2020-05-06       Impact factor: 3.838

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.